That deal would make me ecstatic however I don't think its realistic. Thats would be quite a leap of faith for a drug who has nothing other than phase 1 under its belt. Dont' get me wrong I think things look good but that might be a little rich at this point. Now if the trial starts and we get a good result at the first interim results I think something like that deal you cited would be doable. I'd prefer to hold off partnering just a bit longer. Although I'd like to see a partner in the mid term
This, and positive Ridaforolimus news will make this a winner. We do not have to wait too much longer for Rida, which would propel the SP much higher than the '534 news, imho, as we would be closer in hvaving a real product....